TumorDiagnostik & Therapie

LinksSchließen

Referenz

Munster P, Krischer J, Tamura R. et al.
A randomized community-based trial of an angiotensin converting enzyme inhibitor, lisinopril or a beta blocker, carvedilol for the prevention of cardiotoxicity in patients with early stage HER2-positive breast cancer receiving adjuvant trastuzumab.
San Antonio Breast Cancer Symposium 2018 Abstr. GS5-01

Bibliographische Angaben herunterladen

Aufrufen in: